相关实验视频

Updated: Jan 7, 2026

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

Published on: June 24, 2019

丁醇通过抑制VEGFA表达来缓解HUVEC中的血管生成:整合网络药理学和实验验证

Sichong Yang¹, Dan Mu¹, Xiaoting Li²

¹Ophthalmology Department, The 92493 Military Hospital of PLA, Huludao City, Liaoning Province, People's Republic of China.

Scientific reports

|December 28, 2025

概括

路特通过抑制血管生成,显示了与年龄相关的黄斑变性 (AMD) 的治疗潜力. 这项研究发现,氨酸通过降低VEGFA的调节来减少人类脉内皮细胞中的新血管化,这表明它可以用于治疗湿湿的AMD.

科学领域:

眼科医生眼科眼科
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

与年龄相关的黄斑变性 (AMD) 是导致视力丧失的主要原因.
新血管化是湿性AMD的一个关键病理特征.
丁醇是一种天然的黄类化合物,具有潜在的抗炎和抗氧化特性.

研究的目的:

调查黄素在与年龄相关的黄斑退化症 (AMD) 中的治疗潜力和机制.
在体外分析黄素对人类静脉内皮细胞 (HUVECs) 血管生成的影响.

主要方法:

网络药理学被用来识别黄素和AMD之间的重叠目标.
在体外测试 (划痕,穿孔,管形成) 评估了HUVECs中的血管生成.
西方斑点评估了VEGFA蛋白质表达.

主要成果:

网络药理学确定了6个重叠的目标,包括VEGFA,这表明黄素可能通过VEGFA信号抑制AMD新血管化.
素 (25μmol/L) 在体外显著降低了HUVEC的迁移,入侵和管道形成.
素治疗导致VEGFA蛋白表达显著下降.

结论:

丁醇通过抑制VEGFA表达来缓解HUVEC中的血管生成.
氨酸显示出作为新血管AMD治疗候选药物的潜力.

关键词:

在这个过程中,AMD是AMD.卢特奥林是什么? 卢特奥林是什么?新血管化的新血管化.网络药理学网络药理学在VEGF中,VEGF是VEGF.

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts

Published on: January 22, 2020

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...